Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rauck RL et al. – The objective of this article is to review clinical data for the use of long–acting and short–acting opioids in a variety of chronic noncancer pain conditions. Although some patients with chronic pain appear to prefer short–acting opioids, many patients receiving long–acting opioid formulations show improved treatment responses and better perception of quality of life. In addition, the sustained reductions in pain seen with long–acting opioid formulations may promote patients' focus on daily activities rather than on their pain, thereby improving therapy adherence and reducing pain–related anxieties. Long–term clinical trials of these formulations are needed to allow clinicians to make informed decisions about which patient groups might benefit most from these formulations.

Related Articles

Interindividual variability of drug transporters: Impact on opioid treatment in chronic renal failure
European Journal of Pain, 11/12/09    Relevance Score: 93%

Genetic modulation of the pharmacological treatment of pain
Pharmacology & Therapeutics, 11/06/09    Relevance Score: 93%

Assessment and Management of Acute Pain in Adult Medical Inpatients: A Systematic Review
Pain Medicine, 10/14/09    Relevance Score: 93%

What anesthesiologists should know about paracetamol (acetaminophen)
Minerva Anestesiologica, 11/04/09    Relevance Score: 92%

The epidemiology, economic burden, and pharmacological treatment of chronic low back pain in France, Germany, Italy, Spain and the UK: a literature-based review
Expert Opinion in Pharmacotherapy, 11/03/09    Relevance Score: 92%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address